MedPath

Thalidomide in Treating Patients With Gynecologic Sarcomas

Phase 2
Completed
Conditions
Endometrial Cancer
Sarcoma
Registration Number
NCT00006005
Lead Sponsor
New York University Cancer Institute
Brief Summary

RATIONALE: Thalidomide may stop the growth of gynecologic sarcomas by stopping blood flow to the tumor.

PURPOSE: Phase II trial to study the effectiveness of thalidomide in treating patients who have recurrent or persistent gynecologic sarcomas.

Detailed Description

OBJECTIVES:

* Determine the impact on survival and the antitumor effects of thalidomide in patients with sarcomas or carcinosarcoma (mixed mesodermal tumors) of gynecologic origin.

* Determine the safety and side effect profiles of the target dose of this treatment regimen in this patient population.

* Determine the antiangiogenic and immunologic effects of this treatment regimen in these patients.

OUTLINE: Patients receive oral thalidomide daily. Treatment continues in the absence of disease progression or unacceptable toxicity.

Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

PROJECTED ACCRUAL: A total of 60 patients will be accrued for this study within 18 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (10)

North Shore University Hospital

🇺🇸

Manhasset, New York, United States

New York Medical College

🇺🇸

Valhalla, New York, United States

Mount Sinai School of Medicine

🇺🇸

New York, New York, United States

University of Wisconsin Comprehensive Cancer Center

🇺🇸

Madison, Wisconsin, United States

St. Luke's-Roosevelt Hospital Center - Roosevelt Division

🇺🇸

New York, New York, United States

New York Weill Cornell Cancer Center at Cornell University

🇺🇸

New York, New York, United States

Albert Einstein Clinical Cancer Center

🇺🇸

Bronx, New York, United States

Cancer Center of Albany Medical Center

🇺🇸

Albany, New York, United States

St. Vincent's Comprehensive Cancer Center

🇺🇸

New York, New York, United States

NYU School of Medicine's Kaplan Comprehensive Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath